SCAtACS: Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia

Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Other)
Overall Status
Completed
CT.gov ID
NCT05621200
Collaborator
(none)
26
1
3
22.4
1.2

Study Details

Study Description

Brief Summary

The aim of the study is to evaluate the effects on motor and cognitive performance of transcranial alternating current stimulation (tACS) compared to transcranial direct current stimulation (tDCS) and placebo stimulation (sham) in patients with neurodegenerative ataxia to identify a possible rehabilitation protocol.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial stimulation over the cerebellar hemispheres
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Interventional Cross-over Study to Evaluate the Efficacy on Motor and Cognitive Performance of Transcranial Alternating Current Stimulation (tACS) in Patients With Neurodegenerative Ataxia
Actual Study Start Date :
Jan 28, 2021
Actual Primary Completion Date :
Dec 10, 2022
Actual Study Completion Date :
Dec 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transcranial direct current stimulation (tDCS)

Single session of anodal tDCS at 2 mA over the cerebellar hemispheres

Device: Transcranial stimulation over the cerebellar hemispheres
Single session of Transcranial stimulation over the cerebellar hemispheres

Active Comparator: Transcranial alternate current stimulation (tDCS)

Single session of gamma tACS (50 Hz) at 3 mA over the cerebellar hemispheres

Device: Transcranial stimulation over the cerebellar hemispheres
Single session of Transcranial stimulation over the cerebellar hemispheres

Sham Comparator: Placebo stimulation (sham)

Single session of sham tDCS over the cerebellar hemispheres

Device: Transcranial stimulation over the cerebellar hemispheres
Single session of Transcranial stimulation over the cerebellar hemispheres

Outcome Measures

Primary Outcome Measures

  1. Change in the International Cooperative Ataxia Rating Scale (ICARS) Score From Baseline [Baseline (immediately before the intervention) - Immediately after the intervention]

    International Cooperative Ataxia Rating Scale (ICARS): semi-quantitative 100-point scale, yielding a total score of 0 (no ataxia) to 100 (most severe ataxia).

  2. Change in the Scale for the Assessment and Rating of Ataxia (SARA) Score From Baseline [Baseline (immediately before the intervention) - Immediately after the intervention]

    Scale for the Assessment and Rating of Ataxia (SARA): 8-item performance based scale, yielding a total score of 0 (no ataxia) to 40 (most severe ataxia).

Secondary Outcome Measures

  1. Change in Cerebellar Brain Inhibition (CBI) Measurements From Baseline [Baseline (immediately before the intervention) - Immediately after the intervention]

    Cerebellar brain inhibition (CBI) is expressed as motor evoked potential amplitude (average of 10 recordings). Lower values reflect higher inhibition and thus reduced impairment.

  2. Change in Timed Up and Go Test Duration From Baseline [Baseline (immediately before the intervention) - Immediately after the intervention]

    Time (in seconds) that a person takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees, assessed with gait sensors.

  3. Change in Walking Cadence From Baseline [Baseline (immediately before the intervention) - Immediately after the intervention]

    Average Left and Right Steps/Minute during a 60 seconds walk, assessed with gait sensors.

  4. Change in 360° Turn From Baseline [Baseline (immediately before the intervention) - Immediately after the intervention]

    Velocity (Number of Degrees/sec) in making a 360° turn, assessed with gait sensors

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with a cerebellar syndrome and quantifiable cerebellar atrophy
Exclusion Criteria:
  • Severe head trauma in the past

  • History of seizures

  • History of ischemic stroke or hemorrhage

  • Pacemaker

  • Metal implants in the head/neck region

  • Severe comorbidity

  • Intake of illegal drugs

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 ASST Spedali Civili di Brescia Brescia BS Italy 25123

Sponsors and Collaborators

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Investigators

  • Principal Investigator: Barbara Borroni, MD, ASST Spedali Civili di Brescia
  • Principal Investigator: Alberto Benussi, MD, Università degli Studi di Brescia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Barbara Borroni, Professor, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
ClinicalTrials.gov Identifier:
NCT05621200
Other Study ID Numbers:
  • NP4514
First Posted:
Nov 17, 2022
Last Update Posted:
Dec 27, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Barbara Borroni, Professor, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 27, 2022